Insurance companies have to pay for PrEP under federal rules, but some skirt the requirement for free access to the treatment ...
While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...
Fewer people contracted HIV last year than at any point since the rise of the disease in the late 1980s, the United Nations ...
According to a study published in the New England Journal of Medicine, twice-yearly injection of Lenacapavir offers a 96 percent ...
Dan O’Day drives Gilead's mission to end HIV worldwide, pioneering treatments like lenacapavir and championing global health ...
U.S. philanthropist and entrepreneur Bill Gates has opened up about the search for a lifetime HIV vaccine, rather than one ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced The New England Journal of Medicine (NEJM) published the full results ...
Many family physicians may be unaware of doxy PEP as a means of avoiding STIs. “Doxy PEP is an incredible tool that can be ...